Monte Rosa Therapeutics, Inc. (GLUE) Institutional Ownership & Insider Trading
193 institutions reported holding Monte Rosa Therapeutics, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 37 insider trades on Form 4 since 2025-10-01.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
GLUEMonte Rosa Therapeutics, Inc.Follow GLUE — free
—
Price chart with a free account
- Market cap
- 924.8M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
Institutions · all 13F filers
quarter to 30 Jun 2026 · filers in both quarters193 institutions held —% of the shares. Across filers that reported both quarters, shares held changed +7.0%.
Largest moves, shares (millions)
Institutional flow by quarter
net shares added or trimmed, millions · filers in both quarters| Quarter | Holders | Shares held, M | Change | Increased | New | Decreased | Closed |
|---|---|---|---|---|---|---|---|
| Jun 26 | 193 | 93 | +7.0% | 78 | 25 | 56 | 22 |
| Mar 26 | 189 | 87 | +35.5% | 80 | 43 | 40 | 18 |
| Dec 25 | 159 | 64 | +7.0% | 52 | 45 | 40 | 15 |
| Sep 25 | 125 | 60 | -4.2% | 30 | 23 | 37 | 13 |
| Jun 25 | 115 | 62 | +4.6% | 49 | 27 | 18 | 13 |
| Mar 25 | 105 | 60 | -1.7% | 18 | 21 | 40 | 19 |
| Dec 24 | 104 | 61 | +21.6% | 35 | 28 | 14 | 9 |
| Sep 24 | 81 | 50 | +7.6% | 38 | 12 | 11 | 7 |
Monte Rosa Therapeutics, Inc. — questions
- Who owns Monte Rosa Therapeutics, Inc. stock?
- 193 institutions reported Monte Rosa Therapeutics, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: PRICE T ROWE ASSOCIATES INC /MD/ (10.4%), NEA Management Company, LLC (9.0%), BlackRock, Inc. (8.0%).
- Are Monte Rosa Therapeutics, Inc. insiders buying or selling?
- 37 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.
Every figure on this page comes from Monte Rosa Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.